Perseus Proteomics (TSE:4882) Accounts Payable & Accrued Expense : 円29.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Accounts Payable & Accrued Expense?

Perseus Proteomics's quarterly accounts payable & accrued expense declined from Jun. 2023 (円49.50 Mil) to Sep. 2023 (円43.71 Mil) and declined from Sep. 2023 (円43.71 Mil) to Dec. 2023 (円29.00 Mil).

Perseus Proteomics's annual accounts payable & accrued expense increased from Mar. 2021 (円24.68 Mil) to Mar. 2022 (円134.24 Mil) but then declined from Mar. 2022 (円134.24 Mil) to Mar. 2023 (円66.73 Mil).

Perseus Proteomics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Perseus Proteomics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Accounts Payable & Accrued Expense Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

19.62

53.73

24.68

134.24

66.73

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial												37.99	66.73	49.50	43.71	29.00

Perseus Proteomics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines